DRTS ALPHA TAU MEDICAL LTD

$DRTS Alpha Tau Medical, an Israeli developer of an alpha-radiation cancer therapy, says the FDA-approved expansion of its U.S. recurrent glioblastoma trial from 10 to 20 patients may support a market submission, citing initial discussions. Size: $1.08B market value at $12.29 (16:00 ET Oct 16, 2026); $104.8M cash and deposits at June 30. Caveat: a single-arm feasibility and safety study; reported results cover its first 3 patients. Next: new data at SNO Nov 13; another interim analysis six months after the 5th patient's July treatment.

$DRTS Add another major catalyst to the mix: Fresh clinical data from the trial is locked in for presentation at the upcoming SNO 2026 Annual Meeting

$DRTS Packed catalyst calendar heading into the end of the year. Between ReSTART, ReGAIN, and IMPACT, $DRTS is being validated across multiple solid tumor indications. If these readouts land, that $30 target from Barclays feels conservative. Where do you see the ceiling if all three deliver?

$DRTS is going to blow people's minds in November. 1. We get out of this macro-hell 2. We get DRTS on not one but two Indexes 3. DRTS is going to announce progress on destroying inoperable brain tumors. (FDA just announced a broader IDE.) If you've ever wondered, "What's a good entry point for DRTS?" the stars and sun have aligned so that you'll look back on this day and say, "That was easy."

$DRTS Yesterday started with an ugly morning followed by a near full recovery that was nice to see, looking to see if thar strength continues today, definitely worth paying attention to.

$DRTS At the end of the day, Alpha DaRT technology is solid. Right now it just feels like low volume algo trading dragging things down, pure noise until the next real catalyst drops.

$DRTS Biotech shakeouts are designed to take shares from impatient retail right before major news/data cycles drop. Don't let algorithmic churn trick you into selling a top tier oncology pipeline at a discount.

$DRTS management is in new york today taking 1x1 meetings at the barclays biotech day. funds sit down with the team face to face. this is how institutional interest gets built, quietly, one meeting at a time.

$DRTS begins FDA approval to expand its Alpha DaRT U.S. recurrent glioblastoma REGAIN trial, with new data slated for SNO 2026.

$DRTS this is a beast waiting to be unleashed. Just need to get through this macro churn. Goodluck yall

$DRTS feels like the last chance to load up before $15 and beyond hits hard and $14 is forever in the rear view mirror. Alpha Tau meeting with massive financial institutions in October. Hang on!

$DRTS Just noticed the Stocktwits description is pretty outdated. It lists skin, oral cavity, breast and pancreatic cancer, but doesn’t even mention GBM. That seems like a pretty big omission considering how important the REGAIN glioblastoma program has become for the company. The early results have been some of the most encouraging DRTS has shown, the FDA has continued to allow the trial to expand, and more data is coming in November. If you’re new to DRTS, definitely look into the GBM program because the profile here doesn’t really tell the full story.

$DRTS $SGMO $SLS - wow all 3 of these dropped out of nowhere - after being up - something rotten is going on

$DRTS Getting beat up with the poor macro and interest rates going up as biotechs do. I still believe this is a groundbreaking therapy and longterm should see multiples from here.

$DRTS I believe we will make up today all the ground We lost on Friday, well above 13 today

Didn't think I'd get another chance to add to my $DRTS bag at these levels! Grabbing a few more shares before the next update.

$DRTS Great buying opportunity for $DRTS , all the small caps got killed and so did $DRTS that has now two bites at the apple, one is that the market could bounce back and the second are all the catalysts that are coming up soon, many many catalysts and each one is big, led by the blockbuster GBM treatment

$DRTS is meeting with large institutions. Those institutions are raising their price targets. The catalysts are coming. Get ready for the RUN UP!

$DRTS New week, I’m waiting for the price break out, technically it look like it’s time. I hope this happens even before a major announcement from the company

$DRTS When fundamentals and technicals align like this, I’m very happy to be a shareholder.